Background: Human T-lymphotropic virus type 1 (HTLV-1) is a human retrovirus associated with both HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), which is a chronic neuroinflammatory disease, and adult T-cell leukemia (ATL). The pathogenesis of HAM/TSP is known to be as follows: HTLV-1-infected T cells trigger a hyperimmune response leading to neuroinflammation. However, the HTLV-1-infected T cell subset that plays a major role in the accelerated immune response has not yet been identified.
Introduction
Human T-lymphotropic virus type 1 (HTLV-1) is a human retrovirus associated with chronic and persistent infection of human T cells. While the majority of infected individuals remain healthy lifelong asymptomatic carriers, approximately 3-5% develop aggressive mature T-cell malignancy termed adult T-cell leukemia (ATL) and another 0.25-3% develop a chronic neuroinflammatory disease termed HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) [1] [2] [3] [4] . Furthermore, in some HAM/TSP patients, other autoimmune diseases characterized by multiorgan lymphocytic infiltrates, including uveitis, Sjögren syndrome, arthritis, polymyositis, and alveolitis have been reported [5, 6] . HAM/TSP patients have high frequency of HTLV-1-infected T cells, heightened viral gene expression (in particular, the expression of the viral transactivating gene tax), and virus-specific immune responses, including increased production of proinflammatory cytokines such as IL-6, IL-12, and IFN-c [7] [8] [9] . Neuropathological findings have demonstrated focal infiltrates of HTLV-1-infected CD4 + T cells, CD8 + T cells, and macrophages in the central nervous system (CNS) [10] . It has been suggested that together with viral gene expression and cellular signaling mechanisms, HTLV-1-infected T cells trigger a strong virus-specific T cell response, leading to CNS inflammation and autologous tissue damage. We hypothesized [11, 12] that these ''pathogenic'' HTLV-1-infected T cells may trigger chronic hyperimmune responsiveness in HAM/ TSP patients, and thus they might be an important target for clinical therapeutic interventional strategies.
HTLV-1 has been reported to infect a number of cell types in vitro and in vivo [13] [14] [15] [16] . In our previous study, we used molecular and immunological techniques to demonstrate that CD4 + CD25 + T cells are the predominant viral reservoir in the peripheral blood [12] . In healthy individuals, subsets of CD4 + CD25 + T cells, termed regulatory T cells or Treg cells, has been demonstrated to be hyporesponsive to antigenic stimulation and is reported to suppress the proliferation and cytokine production of CD4 + CD25 2 and CD8 + effector T cells in vitro [17] . Although Treg cells are phenotypically similar to activated T cells, they can be identified ex vivo by the intracellular expression of the transcriptional regulator Foxp3 [18] , which is critical for the development and function of Treg cells in both mice and humans [17] . Previous studies have observed significant reductions in Foxp3 expression and/or Treg function in several human autoimmune diseases, including multiple sclerosis (MS), myasthenia gravis, and type I diabetes [17, 19] , suggesting that defects in Foxp3 expression and/or Treg function may precipitate the loss of immunological tolerance. In our recent study, we reported that CD4 +
CD25
+ T cells from HAM/TSP patients exhibited reduced Foxp3 expression levels compared to healthy individuals and that this reduction was associated with a loss of suppressor function [20] . Furthermore, overexpression of a single HTLV-1 gene (tax) was capable of reducing Foxp3 expression and dampening the suppressive function of healthy donor CD4 + CD25 + T cells [20] . These observations suggest that persistent T cell activation in HAM/TSP patients triggered by viral antigens, e.g., HTLV-1 tax, that are associated with Foxp3 downregulation may result in decline of the CD4 + CD25 + Foxp3
+ Treg cell population and accumulation of CD4 + CD25 + Foxp3 2 T cells that lack suppressive function but are capable of exacerbating the disease process. Therefore, we hypothesize that in HAM/TSP patients, the Foxp3 2 HTLV-1-infected CD4 + CD25 + T cells may contain an immunopathogenic T cell subset that can accelerate the immune response. Thus far, however, the role of Foxp3-negative CD4
+

CD25
+ T cells has not been addressed in the pathogenesis of HAM/TSP.
To detect these HAM/TSP ''pathogenic T cell'' subsets from the pool of HTLV-1-infected T cells, it was important to define additional immunological markers of HTLV-1 infection in HAM/ TSP patients. Although ATL cells have also been shown to have HTLV-1-infected CD4
+ cells with high expression of CD25 + [21] , a recent study demonstrated that ATL cells expressed the chemokine receptor CCR4, which is known to be selectively expressed on T helper type 2 (Th2) cells and Treg cells subsets [22] . More recently, it has been observed that CCR4 is expressed on Th17 cells [23] . Furthermore, it has been reported that HTLV-1 preferentially transmits to CCR4 +
CD4
+ T cells through the CCR4 ligand (CC chemokine ligand (CCL) 22), which is induced by tax and consequently expressed on the surface of HTLV-1-infected T cells [24] . However, it has been demonstrated that in HAM/TSP patients, HTLV-1-infected CD4 + CD25 + T cells produce the Th1 cytokine IFN-c and contain fewer Foxp3 + Treg cells [20] . Therefore, it would be of interest to determine the percentage of CCR4-expressing cells in the HAM/TSP CD4 + CD25 + subset and whether CCR4 can be used as a marker of HTLV-1-infected T cells in HAM/TSP.
In the present study, we demonstrated that CD4 
CCR4
+ T cells in HAM/ TSP patients were producing extraordinarily high levels of IFN-c, while this T cell subset produced low levels of IFN-c in healthy donors. Furthermore, the expression levels of IL-2, IL-4, IL-10, and IL-17 in the CD4
+ T cells in HAM/TSP patients were low compared to the corresponding levels produced by this T cell subset in healthy individuals. Further, it is noteworthy that these functional alterations were specific to the CD4
+ T cell subtype (HTLV-1-infected T cells). Moreover, the frequency of these IFN-c-producing CD4
Foxp3
2 T cells was increased and found to be correlated with disease severity in HAM/TSP patients. Thus, our study is the first to demonstrate that abnormal IFN-c-producing CCR4
+ T cells, which are rare in healthy individuals, are increased in HTLV-1-infected T cells in HAM/TSP patients.
Results
CD4
+ CD25 + CCR4 + T cells are the main reservoir of HTLV-1 and are present in high numbers in HAM/TSP patients To determine whether CCR4 can be used as a cell surface marker to identify HTLV-1-infected T cells in HAM/TSP patients as reported in ATL cells [22] , we separated peripheral blood mononuclear cells (PBMCs) from HAM/TSP patients into the following T cell subtypes by FACS sorting: CD4
, and CD4
+ ( Figure 1A ). The purity of each separated cell subtype was approximately 99% ( Figure  S1 ). The HTLV-1 proviral DNA load was then determined within each population by real-time quantitative PCR. As shown in Figure 1B (means of 8 HAM/TSP patients), the HTLV-1 proviral DNA load was higher in CD4 +
CD25
+ T cells than in CD4 + CD25 2 T cells; this result is consistent with those of previous studies [12] . Moreover, when CCR4 was used to segregate these T cell subsets, increased HTLV-1 provirus levels were also observed in CD4 +
CCR4
+ cells, including CD25 2 cells. Importantly, the CD4 +
CD25
+ CCR4 + T cell subset was infected with HTLV-1 at significantly higher frequencies than for the CD4
CCR4
2 T cell subset (p = 0.017). If the HTLV-1 provirus integrates at the rate of 1 copy per cell [14, 25] , the proviral DNA load (115.65635.28 copies/100 cells) in CD4
+ T cells suggests that the majority (if not all cells) of this population is infected with HTLV-1.
These results directly demonstrated that CD4 + CD25 + CCR4 + T cells are the main virus reservoir in HAM/TSP patients; therefore, we aimed to determine the percentage of this T cell subset in the PBMCs to the total HTLV-1 proviral DNA in each HAM/TSP patient. As shown in Figure 1C , the amount of HTLV-1 proviral DNA (which is the percent of HTLV-1-infected cells in PBMCs, provided the provirus integrates at the rate of 1 copy per cell) and the percentage of CD4 + CD25 + CCR4 + T cells were comparable in the HAM/TSP patients with low to medium HTLV-1 viral loads (HAM 1, HAM 5, HAM 6, HAM 4, HAM 7, and HAM 2). In the HAM/TSP patients with higher virus loads (HAM 10 and 11), the number of virus-infected cells (virus load) was demonstrated to be higher than the percentage of CD4 +
CD25
+ CCR4 + T cells, suggesting that other cell populations may also be infected in these patients.
As shown in the histogram plot in Figure 1A , CD4 Although CCR4 is known to be selectively expressed on Th2, Th17, and Treg cells [23, 26] in healthy individuals, the expression levels of Foxp3, a hallmark of Treg cells [17, 18] , has been reported to be reduced in HAM/TSP patients [20, [27] [28] [29] . Therefore, it is interesting to compare the Foxp3 expression levels in CD4 + CD25 + CCR4 + T cells between HAM/TSP patients, ATL patients, and uninfected healthy donors (HDs). As reported previously [30] 
2 population of ATL patients (lower right panel, Figure 2 ) may reflect the presence of leukemia cells. However, a more detailed analysis of these FACS plots demonstrated an increased number of Foxp3 2 cells in the Figure 2 ). This observation suggested that the number of
Analysis of these T cell subsets based on Foxp3 expression in
2 T cells in the total PBMCs in HAM/TSP patients (n = 11) as compared to that in HDs (n = 8) (left panel, Figure 3A ; p = 0.001). The percentage of Foxp3 2 cells in the CD4 + CD25 + CCR4 + subset was also higher in HAM/TSP patients than in HDs (left panel, Figure 3B ; p = 0.002). Further, the percentage of Foxp3 + cells in this subset was decreased in HAM/TSP patients than in HDs (right panel, Figure 3B ; p = 0.002), and the frequency of Foxp3 + cells in this subset in the total PBMCs was equivalent in HAM/TSP patients and HDs (right panel, Figure 3A ; p = 0.817).
To determine whether increased CD4
T cells in HAM/TSP patients were proliferating in vivo, we examined the expression levels of Foxp3 and Ki67 in CD4
Ki67 is a marker of proliferating cells. As shown in Figure 3C , Ki67-positive cells were predominantly confined to the CD4 
cells produce multiple proinflammatory cytokines and overproduce IFN-c in HAM/TSP
CCR4-expressing CD4
+ T cells include Th2, Th17, and Treg cells, and they do not tend to produce Th1 cytokines such as IFNc in healthy individuals [26] . However, it has been reported that HTLV-1-infected CD4 + T cells in HAM/TSP patients can produce IFN-c [20, 32] . Therefore, we investigated the intracellular proinflammatory cytokine expression in the 
CCR4
+ T cells and was found to be significantly increased compared to that in HDs, while IL-2 and IL-17 production was decreased in HAM/TSP patients than in HDs. In ATL patients, although PMA and ionomycin stimulation reduced the Foxp3 expression levels (lower left panel, Figure 2 ), the expression of all 3 cytokines in CD4
+ CD25 + CCR4 + T cells was significantly decreased (Figures 4A, B) .
Results of the intracellular flow cytometry revealed that Figure 4 and Figure 5A . Importantly, these alterations were not observed in other cell subtypes ( Figure 5B ), and this functional alteration in cytokine production was specific to the CD4 + CD25 + CCR4 + T cells of HAM/TSP patients. The frequency of IFN-c producing CD4
+ CD25 + CCR4 + T cells correlates with disease severity in HAM/TSP
In this study, we demonstrated that IFN-c production is specifically increased in the CD4 +
CD25
+ CCR4 + T cells in HAM/ TSP patients (Figures 4 and 5) . We then measured the percentages of the IFN-c-producing CD4 +
+ CCR4 + T cells to the total PBMCs in 8 HDs, 11 HAM/TSP, and 5 ATL patients. As shown in Figure 7A , the frequency of this population was significantly and specifically increased in HAM/TSP patients than in HDs (p,0.01) and ATL patients (p,0.05). 2 T cells were prepared using FACS sorting from 4 HDs and 4 HAM/TSP patients and cultured for 7 days, after which the magnitude of proliferation between the 2 groups was compared. As shown in Figure 8A, 
CCR4
2 T cells from 4 HDs and 4 HAM/TSP patients by FACS sorting and cultured them for 7 days, following which we compared the magnitude of proliferation between these cell populations ( Figure 8B ). CD4 
2 T cells from HDs did not.
Discussion
HAM/TSP is a neuroinflammatory disorder etiologically associated with a human retrovirus (HTLV-1). The pathogenesis of this disorder has been demonstrated to involve HTLV-1-infected T cells, which induce chronic hyperimmune responses that can lead to an immunopathological process in the CNS of genetically susceptible infected individuals [11, 36] . We hypothesized that there may exist subpopulations of chronically activated ''pathogenic T cells'' in HTLV-1-infected cells of HAM/TSP patients that may function to accelerate inflammation and that these cells could be an important target for clinical therapeutic interventions. It was important to initially determine markers of HTLV-1-infected T cells in HAM/TSP patients. In our previous studies, we have demonstrated that CD4 + CD25 + T cells are the predominant viral reservoir in the peripheral blood of HAM/TSP patients [12] , although CD8 + T cells [14] , macrophages [13, 16] and dendritic cells [15] are also infected in HAM/TSP. Recently, the chemokine receptor CCR4 has been shown to be expressed on HTLV-1-infected ATL cells [22] . Since CCR4 is known to be selectively expressed on Th2, Th17, and Treg cells [23, 26] , and since ATL cells have been shown to express high levels of Foxp3, a specific marker of Treg [22, 31] , it was hypothesized that ATL cells may be derived from Treg [37] . However, in HAM/TSP patients, [20, [27] [28] [29] . Furthermore, it has been demonstrated that HTLV-1-infected CD4 + T cells in HAM/TSP patients produce Th1 cytokines (IFN-c) [20, 32] . Therefore, it was expected that CD4 + CD25 + T cells might exhibit reduced CCR4 expression in HAM/TSP patients. However, we clearly demonstrated that CCR4 was selectively overexpressed on HTLV-1-infected T cells. We also demonstrated that the majority of CD4 + CD25 + CCR4 + T cells were infected with HTLV-1 and that this T cell subset was increased in HAM/TSP patients (Figure 1 Patients with HAM/TSP exhibit a chronic inflammatory disorder characterized by accumulation of activated CD4 + and CD8 + T cells [38] . CD4 +
CD25
+ T cells from HAM/TSP patients also exhibit an activated phenotype marked by decreased expression of CD45RA together with increased expression of IFN-c compared to the same subset in healthy individuals [20] . Furthermore, we previously demonstrated that HTLV-1 tax overexpression was capable of reducing Foxp3 expression, and the HTLV-1 tax mRNA expression in PBMCs of HAM/TSP was elevated [8, 20] . Therefore, we hypothesized that persistent T cell activation in patients with HAM/ TSP triggered by viral antigens such as HTLV-1 tax together with the downregulation of Foxp3 may result in decline of the CD4
+ Treg population and accumulation of Foxp3-negative CD4
+ T cells that lack suppressive function, but are capable of exacerbating the disease process. In this study, we have demonstrated that CD4
2 T cells were proliferating in vivo (Ki67 positive) (Figure 3) , and the frequency of this population was increased in HAM/TSP patients (Figure 2) . Moreover, analysis of the cytokine expression in this CD4
Foxp3
2 T cell subset demonstrated that these cells were unique because they produce multiple proinflammatory cytokines such as IL-2, IL-17, and few IFN-c in healthy individuals while CD4
+ T cells (Treg cells) did not (Figure 4) . Furthermore, it was demonstrated that HAM/TSP patients exhibited 
+ T cells that do not produce such cytokines (Figure 3) . Rather, the CD4
2 T cells in HAM/TSP were increased and found to overproduce IFN-c (Figures 3 and 4) . Further, the frequency of these IFN-c-producing CD4
2 T cells may have a functional consequence since this population was associated with increased clinical disease activity and severity in HAM/TSP (Figure 7) . These results suggest that IFN-c-producing CD4
2 T cells may play an important pathogenic role in HAM/TSP by augmenting inflammation in the CNS. Thus, we have defined a unique T cell subset-IFN-c
+ T cells-that is specifically increased in HAM/TSP (tentatively designated T HAM cells) and is rarely encountered in healthy individuals. Since some HAM/TSP patients are known to experience complications with other autoimmune disorders [5, 6] , it would be of interest to determine if this newly 
+ with no cytokine production) in the CD4
+ T cell subset were high in HAM/TSP and low in ATL (Figure 2 ). This differential T HAM /Treg ratio in HTLV-1-infected T cells may be associated with the different immune responses observed between HAM/TSP and ATL. ATL patients have very low frequencies of Tax-specific CD8 + T cells in PBMCs and tend to develop opportunistic infections [21] , while HAM/TSP is characterized by extraordinarily high levels of Taxspecific CD8
+ CTL [7, 8, 11, 40, 41] . It has been reported that the immunosuppressive function of CD4 +
CD25
+ T cells with high expression of Foxp3 in ATL patients is intact [42] . Thus, the CD4
+ leukemia T cells with increased Treg function may also contribute to the clinically observed cellular immunodeficiency in ATL patients. However, HAM/TSP patients show extremely high cellular and humoral immune responses such as high frequencies of Tax-specific CD8 + T cells as well as cytomegalovirus (CMV)-specific CD8 + T cells in PBMCs [7, 8, 28] ; high antibody titer to HTLV-1 [6] ; and increased production of proinflammatory cytokines such as IL-6, IL-12, and IFN-c [9] . It has been reported that HAM CD4 +
+ T cells with low expression of Foxp3 [20] or HTLV-1 Tax-expressing Foxp3 + Treg cells [45] are defective in their immunosuppressive function. Here, we demonstrate that HTLV-1-infected IFN-c overproducing CD4
2 T cells (T HAM cells) are increased in HAM/TSP patients, and these levels can be correlated with disease severity. Thus, CD4
+ T cells with increased proinflammatory function together with a defective Treg compartment [20, [27] [28] [29] may overcome the regulatory effect of HTLV-1-uninfected Treg cells [45] and at least partly account for the heightened immune response observed in HAM/TSP patients. Collectively, these observations support the hypothesis that imbalance of the T HAM /Treg ratio in HTLV-1-infected CD4
+ T cells is an important factor that contributes to immunological differences of the host immune response between HAM/TSP and ATL ( Figure S2 ).
The high Foxp3 expression without cytokine production and low Foxp3 expression with cytokine production in CD4 + CD25 + CCR4 + T cells ( Figure 3A ) are consistent with recent reports demonstrating that Foxp3 can target and repress the transcriptional activity of NFAT-AP-1 complexes present at the cytokine promoter [43] . We have previously reported that overexpression of HTLV-1 tax was capable of reducing Foxp3 expression [20] 
Materials and Methods
Subjects, cell preparation, and determination of CSF neopterin concentrations
A total of 11 HAM/TSP patients, 8 healthy donors, and 5 ATL patients (chronic type) participated in this study. Written informed consents were obtained from all the subjects in accordance with the Declaration of Helsinki as part of a clinical protocol reviewed and approved by the Institutional Ethics Committee (St. Marianna University). Blood samples were collected from the subjects, peripheral blood mononuclear cells (PBMCs) were separated by centrifugation over Ficoll-Hypaque gradients, and the cells were cryopreserved in liquid nitrogen until testing. HAM/TSP was diagnosed according to the guidelines defined by the WHO, and ATL was diagnosed on the basis of the criteria proposed by Shimoyama [46] . HTLV-1 seropositivity was determined by particle agglutination (Serodia-HTLV-1; Fujirebio, Japan) and confirmed by western blotting (SRL, Japan). Clinical disease severity was evaluated by Osame's motor disability scale (Table 1) [6] . In some experiments, CD4 + T cells were negatively selected from the PBMCs by using magnetic beads (MACS CD4 + T cell isolation kit; Miltenyi Biotec, Germany), according to the manufacturer's instructions. FACS cell sorting was performed using JSAN (Bay Bioscience, Japan), and purity after sorting was approximately 99% ( Figure  S1 ). Neopterin concentration was measured by high-performance liquid chromatography with fluorometric detection methods [33] (SRL, Japan).
Flow cytometry
Cells were immunostained with various combinations of the following fluorescence-conjugated antibodies that served as cell surface markers: CD4 (OKT4; eBioscience, San Diego, CA), CD25 (M-A251; BD Biosciences, San Diego, CA), CCR4 (1G1; BD Biosciences). In some experiments, cells were fixed by a staining buffer set (eBioscience), then intracellularly stained with the antibodies to Foxp3 (PCH101; eBioscience) and Ki67 (B56; BD Biosciences). For intracellular cytokine staining, the cells were stimulated for 5 h with phorbol 12-myristate 13-acetate (PMA) and ionomycin (Sigma, Japan) in the presence of monensin (Golgistop; BD Biosciences). Cells were fixed and stained with the antibodies to IFN-c (B27; BD Biosciences), IL-2 (MQ1-17H12; BD Biosciences), IL-10 (JES3-9D7, eBioscience), and IL-17A (eBio64-
; eBioscience). Flow cytometric analysis was performed on a FACSCalibur cytometer (BD Biosciences). Data processing was performed using FlowJo software (TreeStar, San Diego, CA).
Real-time PCR
The HTLV-1 proviral DNA load was measured as previously described [8] . 
CCR4
+ cells for the analysis. Total RNA was isolated from cells using ISOGENE (Nippon Gene, Japan). The first-strand cDNA was synthesized with random hexamers and reverse transcriptase (ReverTraAce; Toyobo, Japan) using 1 mg of total RNA in a reaction volume of 20 ml. Real-time PCR reactions were carried out using TaqMan Universal Master Mix (Applied Biosystems) and Universal Probe Library assays designed using ProbeFinder software (Roche Applied Science). The primer sequences and Universal Probe numbers used are available upon request (Roche Applied Science). ABI Prism 7500 SDS was programmed to an initial step of 2 min at 50uC and 10 min at 95uC, followed by 45 cycles of 15 sec at 95uC and 1 min at 60uC. The primers used were as follows: IFN-c, 59-GGCATTTTGAA-GAATTGGAAAG-39 (forward) and 59-TTTGGATGCTCTGGT-CATCTT-39 (reverse) (probe No. 21); IL-2, 59-AAGTTTTA-CATGCCCAAGAAGG-39 (forward) and 59-AAGTGAAAGTTT-TTGCTTTGAGCTA-39 (reverse) (probe no. 65); IL-17A, 59-TGGGAAGACCTCATTGGTGT-39 (forward) and 59-GGA-TTTTCGTGGGATTGTGAT-39 (reverse) (probe No. 8); and GAPDH, 59-AGCCACATCGCTCAGACA-39 (forward) and 59-GCCCAATACGACCAAATCC-39 (reverse) (probe no. 60). The primers and probe for detecting the HTLV-1 tax mRNA load were used as described previously [8] . The primers and probe for IL-4 and IL-10 were used from TaqManH Gene Expression Assays (IL-4: Hs: Hs00932431_m1, IL-10: Hs00174086_m1). Relative quantification of mRNA was performed using the comparative threshold cycle method using GAPDH as an endogenous control. For each sample, target gene expression was normalized to the expression of GAPDH.
To determine the relative expression levels, the following formula was used: target gene expression = 2 5 per well) without any mitogenic stimuli. RPMI 1640 with L-Glutamine (Wako, Japan) supplemented with 5% human AB serum (Gibco-Invitrogen, NY), penicillin, and streptomycin (Wako, Japan) was used as the culture medium. After 6 days of culture, 1 mCi tritium thymidine was added to each well, and the cells were cultured for an additional 16 hours. A liquid scintillation counter was used to measure the proliferation. Cultures were performed in triplicate for each experiment, and the average proliferation data was used for analysis.
Statistical analyses
The Wilcoxon signed-rank test was used to compare the HTLV-1 provirus load between CD4 
CCR4
+ T cells in PBMCs, HTLV-1 tax proviral load in PBMCs, clinical severity score, and concentration of neopterin in the CSF. Statistical analyses were performed using Statcel2 software. 
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